US$ 20.65
bpc-157 clinical trials human evidence review safety regulatory status BPC-157 bpc-157 human clinical trials oral
Description
Prior to the study, all subjects gave written informed consent

Evidence shows BPC 157 promotes fibroblast multiplication and movement which is key to forming extracellular matrix and laying down collagen fibers

This reduces blood flow to superficial tissues, limiting the delivery of inflammatory cells and mediators to injury sites
The dose is given intramuscularly to make sure its absorbed well
Sharabi A, Cohen E, Sulkes J, Garty M (2003) Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route
